Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.820
-0.070 (-2.42%)
At close: Feb 20, 2026, 4:00 PM EST
2.790
-0.030 (-1.06%)
After-hours: Feb 20, 2026, 4:39 PM EST
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $356.18 million as of February 20, 2026. Its market cap has increased by 61.17% in one year.
Market Cap
356.18M
Enterprise Value
251.76M
1-Year Change
61.17%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $356.18M, an increase of 204.34%. That is a compound annual growth rate of 25.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 356.18M | 44.62% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 364.53M |
| Adlai Nortye | 358.67M |
| Atea Pharmaceuticals | 358.60M |
| Monopar Therapeutics | 358.25M |
| Cybin | 349.75M |
| Aclaris Therapeutics | 347.25M |
| Rezolute | 344.86M |
| Vanda Pharmaceuticals | 343.42M |